The first step to treating obesity is for patients and providers to recognize it as a medical condition with effective available treatments

Wegovy highlights of prescribing information, Novo Nordisk (2024) The risk of depression, anxiety, and suicidal behavior in patients with obesity on glucagon-like peptide-1 receptor agonist therapy, Scientific Reports (2024) Decreased risk of anxiety in diabetic patients receiving glucagon-like peptide-1 receptor agonist: A nationwide, population-based cohort study, Frontiers in Pharmacology (2022) Most GLP-1 medications correlated with a lower likelihood of anxiety and depression diagnoses, Epic Research (2024) Dopamine release in the midbrain promotes anxiety, Biological Psychology (2021) Dopamine primes the brain for enhanced vigilance, MIT News (2018) Why your cardiologist may prescribe semaglutide (Wegovy), Yale Medicine (2024) Medically accurate: SingleCares Medical Review Board analyzes all of our content to confirm its in line with current medical advice

All PlexusDx medications are HSA and FSA eligible, require no insurance, and involve no membership fees, making it accessible to prioritize your fertility planning without financial barriers
It slows down how fast your stomach empties, making you feel full longer
CJC 1295 und Ipamorelin Die perfekte Kombination Die Kombination von CJC 1295 und Ipamorelin ist besonders beliebt, da beide Peptide synergistisch wirken
Belle offers compounded semaglutide and compounded tirzepatide injections, plus branded Wegovy and Zepbound pens